优势价格
快速发货
品质保证
技术支持
400-920-2911 sales@csnpharm.cn
Potassium Channel
| 货号 | 产品名 | CAS号 | 信息 |
|---|---|---|---|
| CSN20024 | XE991 | 122955-42-4 | XE991 is a potent and selective blocker of KV7 (KCNQ) voltage-gated potassium channels which blocks KV7.2+7.3 (KCNQ2+3) / M-currents (IC50 = 0.6 - 0.98 μM) and KV7.1 (KCNQ1) homomeric channels (IC50 = 0.75 μM) but is less potent against KV7.1/minK channels (IC50 = 11.1 μM). |
| CSN20025 | XE991 2HCl | 122955-13-9 | XE991 2HCl is a potent and selective blocker of KV7 (KCNQ) voltage-gated potassium channels which blocks KV7.2+7.3 (KCNQ2+3) / M-currents (IC50 = 0.6 - 0.98 μM) and KV7.1 (KCNQ1) homomeric channels (IC50 = 0.75 μM) but is less potent against KV7.1/minK channels (IC50 = 11.1 μM). |
| CSN25285 | VU0810464 | 2126040-21-7 | VU0810464 is a potent and selective non-ureaG protein-gated inwardly-rectifying potassium channels (GIRK, Kir3) activator,with EC50 of 720 nM for GIRK1/4 channels. |
| CSN23185 | VU 0463271 | 1391737-01-1 | VU0463271 is a potent KCC2 antagonist, with an IC50 of 61 nM. |
| CSN27561 | VU0134992 hydrochloride | 1052515-91-9 | VU0134992 hydrochloride is the first subtype-preferring, orally active and selective Kir4.1 potassium channel pore blocker, with an IC50 of 0.97 µM. VU0134992 hydrochloride is 9-fold selective for homomeric Kir4.1 over Kir4.1/5.1 concatemeric channels (IC50=9 µM) at -120 mV. |
| CSN25451 | Tetraethylammonium chloride | 56-34-8 | Tetraethylammonium chloride is a non-selective potassium channel blocker. Tetraethylammonium chloride is a good substrate for organic cation transporter (OCTN1). Tetraethylammonium chloride antitumor properties. |
| CSN28441 | Tannic Acid | 1401-55-4 | Tannic acid is a novel hERG channel blocker with IC50 of 3.4 μM. |
| CSN23781 | SKA-31 | 40172-65-4 | SKA 31 is an activator of KCa3.1 and KCa2 channels with EC50 of 260, 2900, 2900 nM for KCa3.1, KCa2.1 and KCa2.2 respectively. |
| CSN27571 | Ropivacaine mesylate | 854056-07-8 | Ropivacaine mesylate is a long-acting amide local anaesthetic agent for a spinal block and effectively blocks neuropathic pain. Ropivacaine blocks impulse conduction via reversible inhibition of sodium ion influx in nerve fibressup>. Ropivacaine is also an inhibitor of K2P (two-pore domain potassium channel) TREK-1 with an IC50 of 402.7 μM in COS-7 cell's membrane. |
| CSN27570 | Ropivacaine | 84057-95-4 | Ropivacaine is a potent sodium channel blocker and blocks impulse conduction via reversible inhibition of sodium ion influx in nerve fibrese. Ropivacaine is also an inhibitor of K2P (two-pore domain potassium channel) TREK-1 with an IC50 of 402.7 μM in COS-7 cell's membrane. Ropivacaine is a local anesthetic agent widely used for regional anesthesia and neuropathic pain management in vivo. |
| CSN23838 | Pinacidil H2O | 85371-64-8 | Pinacidil monohydrate, an antihypertensive drug, is a potassium channel activator. |
| CSN25559 | NS 5806 | 426834-69-7 | NS5806, a KV4.3 channel activator, increases peak current amplitude of the potassium channel Kv4.3 with EC50 of 5.3 uM. NS5806 also slows Kv4.3 and Kv4.2 current dacay in channel complexes containing KChIP2. |
| CSN25560 | NS19504 | 327062-46-4 | NS19504 is a selective activator of large-conductance Ca2+-activated potassium channels (BKCa, KCa1.1) with EC50 of 11 μM. |
| CSN21324 | Naminidil | 220641-11-2 | Naminidil is a cyanoguanidine KATP opener. |
| CSN27562 | ML418 | 1928763-08-9 | ML418 is the first potent, selective and CNS penetrating blocker of Kir7.1 potassium channel (IC50, 310 nM), which also potently inhibits Kir6.2/SUR1, and exhibits superior selectivity over other Kir channels. |
| CSN18626 | ML365 | 947914-18-3 | ML365 is a selective small molecule inhibitor of TASK1 (KCNK3) with IC50 of 4 nM (thallium influx fluorescent assay) and 16 nM (automated electrophysiology assay). |
| CSN19856 | ML 213 | 489402-47-3 | ML213 is an activator of Kv7.2 (KCNQ2) and Kv7.4 (KCNQ4) channels with EC50s of 230 and 510 nM respectively. |
| CSN25288 | ML 297 | 1443246-62-5 | ML 297 is a potent and selective GIRK1/2 activator, with an EC50 of 0.16 μM. |
| CSN18790 | Mitiglinide Calcium Hydrate | 207844-01-7 | Mitiglinide calcium is a drug for the treatment of type 2 diabetes and it is a highly selective KATP channel antagonist. |
| CSN20022 | Linopirdine | 105431-72-9 | Linopirdine is a blocker of KV7 (KCNQ) voltage-gated potassium channels which blocks KV7.1 + 7.3 (KCNQ2 + 3) / M-currents (IC50 = 4 - 7 μM) and KV7.1 (KCNQ1) homomeric channels (IC50 = 8.9 μM), and is a putative cognition-enhancing drug. |
| CSN20023 | Linopirdine 2HCl | 113168-57-3 | Linopirdine 2HCl is a blocker of KV7 (KCNQ) voltage-gated potassium channels which blocks KV7.1 + 7.3 (KCNQ2 + 3) / M-currents (IC50 = 4 - 7 μM) and KV7.1 (KCNQ1) homomeric channels (IC50 = 8.9 μM), and is a putative cognition-enhancing drug. |
| CSN20179 | Isopimaric Acid | 5835-26-7 | Isopimaric acid, a natural product isolated and purifed from the herbs of Daemonorops draco Blume, potently opens large conductance Ca-activated K+ channels and also possibly has an antagonistic interaction with reserpine which may render the antibiotics inactive. |
| CSN24792 | IK1 inhibitor PA-6 | 500715-03-7 | IK1 inhibitor PA-6 (PA-6), a pentamidine analogue, is a selective and potent IK1 (KIR2.x ion-channel-carried inward rectifier current) inhibitor, with IC50 values of 12-15 nM for human and mouse KIR2.x currents. IK1 inhibitor PA-6 (PA-6) elevates KIR2.1 protein expression and induces intracellular KIR2.1 accumulation. IK1 inhibitor PA-6 (PA-6) has the potential to treat atrial fibrillation and arrhythmia[1][2][3]. |
| CSN25242 | ICA 110381 | 325457-99-6 | ICA 110381 is a KV7.2/7.3 activator with EC50 of 0.38 μM. |
| CSN20444 | ICA 069673 | 582323-16-8 | ICA 069673 selectively inhibit KV7.2 (KCNQ2) and KV7.3 (KCNQ3) channel with EC50 of 0.69 μM and has no measurable activity over a panel of cardiac ion channels. |
| CSN21276 | H100 | 643727-55-3 | H100 is a Cl- transport inhibitor, with partial effects against both the NaK2Cl cotransporter and the Band 3 anion exchanger, but no effect against KCl cotransporter, in human erythrocytes. |
| CSN24161 | GSK369796 2HCl | 1010411-21-8 | GSK369796 is an anti-malaria drug candidate. |
| CSN18763 | Flupirtine Maleate | 75507-68-5 | Flupirtine maleate is a non-opioid analgesic of KV7 potassium channels. Flupirtine also inderectly antagonizes NMDA receptor and GABAa receptors. It exhibits the relaxantion of muscles and neuroprotective. |
| CSN15660 | Daurisoline | 70553-76-3 | Daurisoline, a natural product isolated and purified from the roots of Menispermum dauricu with antiarrhythmic effects, exerts a blocking effect on hERG at concentrations below 30 uM, but does not affect the expression and function of the hERG channel. |
| CSN26156 | CyPPA | 73029-73-9 | CyPPA is a selective activator of both KCa2.3 and KCa2.2 with EC50 values of 5.6μM and 14μM, respectively. |
| CSN22765 | CLP 257 | 1181081-71-9 | CLP 257 is a selective KCC2 K+-Cl- cotransporter activator with EC50 of 616 nM. |
| CSN23548 | Cloperastine HCl | 14984-68-0 | Cloperastine hydrochloride inhibits the hERG K+ currents in a concentration-dependent manner with an IC50 value of 27 nM. |
| CSN23809 | Cloperastine Fendizoate | 85187-37-7 | Cloperastine fendizoate inhibits the hERG K+ currents in a concentration-dependent manner with an IC50 value of 27 nM. |
| CSN13101 | Chlorzoxazone | 95-25-0 | Chlorzoxazone, a potassium channel activator, is a centrally acting muscle relaxant used to treat muscle spasm and the resulting pain or discomfort. It is also a CYP2E1 inhibitor with IC50 value of 1.03μM. |
| CSN19508 | Amifampridine | 54-96-6 | Amifampridine is a quaternary ammonium compound that blocks presynaptic potassium channels, subsequently prolongs the action potential and increases presynaptic calcium concentrations, it was approved by the US FDA for the treatment of adults with LEMS. |
| CSN22235 | Almokalant | 123955-10-2 | Almokalant is a class III antiarrhythmic drug, acts as a potassium channel blocker, and inhibits a specific component (Ikr) of the time-dependent delayed rectifier K+ current. |
| CSN21132 | Almitrine Mesylate | 29608-49-9 | Almitrine mesylate is an agonist of peripheral chemoreceptor and inhibits selectively the Ca2+-dependent K+ channel. It can improve chronic obstructive pulmonary disease and nocturnal oxygen desaturation. |
| CSN25452 | 1-EBIO | 10045-45-1 | Activator of epithelial KCa channels, stimulates a large and sustained trans-epithelial Cl- secretory response across T84 monolayers. Induces hyperpolarization to the same magnitude as ACh in aortic value endothelial cells. Promotes embryonic stem cell (ESC) differentiation into cardiomyocytes. |
| CSN25278 | A2793 | 88349-90-0 | A2793 is an inhibitor of TRESK (IC50 value of 6.8 μM for mTRESK). |
| CSN25279 | A2764 2HCl | 861038-72-4 | A2764 dihydrochloride is a selective inhibitor of TRESK (KCNK18) with an IC50 value of 11.8 μM. A2764 can inhibit TRESK in native cells, leading to cell depolarization and increased excitability. |
| CSN27560 | 2,2,2-Trichloroethanol | 115-20-8 | 2,2,2-Trichloroethanol, the active form of the sedative hypnotic drug chloral hydrate, is an agonist for the nonclassical K2P channels TREK-1 (KCNK2) and TRAAK (KCNK4). |
| CSN27563 | (±)-Naringenin | 67604-48-2 | (±)-Naringenin is a naturally-occurring flavonoid. (±)-Naringenin displays vasorelaxant effect on endothelium-denuded vessels via the activation of BKCa channels in myocytes. |
